Frontlight ResearchEarly access
Trial site
Bon Secours Hospital Cork
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer5 trials
- Prostate cancer3 trials
- Colorectal cancer2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Triple-negative breast cancer2 trials
- Childhood cancers1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 313 trials
- Phase 23 trials
- Status
- Completed7 trials
- Active, not recruiting5 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- AbbVie3 trials
- Merck Sharp & Dohme LLC3 trials
- Anthos Therapeutics, Inc.2 trials
- Fundacion Grupo Espanol De Investigacion En Cancer De Mama1 trial
- Genmab1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Active, not recruiting
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026